再生医療の世界市場2024~2028

■ 英語タイトル:Global Regenerative Medicine Market 2024-2028

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR41171-23)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR41171-23
■ 発行日:2023年10月17日
■ 調査対象地域:北米、ヨーロッパ、アジア、その他地域
■ 産業分野:医療
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[再生医療の世界市場2024~2028]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

世界の再生医療市場 2024-2028再生医療市場は、2023年から2028年の間に70110.07百万米ドル成長し、予測期間中のCAGRは23.31%で加速すると予測されています。当レポートでは、再生医療市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。慢性疾患の増加、公的・民間医療機関からの支援の増加、幹細胞治療の採用増加などが市場を牽引しています。

Technavioの再生医療市場は以下のようにセグメント化されています。
用途別
- 腫瘍学
- 筋骨格系
- 皮膚科学
- 免疫・炎症、その他

技術別
- 細胞
- 組織ベース
- 遺伝子治療

地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、今後数年間の再生医療市場の成長を促進する主な理由の1つとして、臨床試験数の増加を挙げています。また、世界の再生医療市場における新たな技術進歩やキメラ抗原受容体T細胞(CAR-T)療法の隆盛は、同市場における大きな需要につながるでしょう。

本レポートでは、再生医療市場について以下の領域をカバーしています。
- 再生医療市場規模
- 再生医療市場の予測
- 再生医療市場の産業分析

強固なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って、本レポートでは、AbbVie Inc.、Amgen Inc.、Baxter International Inc.、Becton Dickinson and Co.、Cook Group Inc.、F. Hoffmann La Roche Ltd.、Gilead Sciences Inc.、Integra Lifesciences Corp.、Johnson and Johnson、Medtronic Plc、Merck and Co. Ltd.、Mesoblast Ltd.、MiMedx Group Inc.、Novartis AG、Nuvasive Inc.、Organogenesis Holdings Inc.、Smith and Nephew plc、Thermo Fisher Scientific Inc.、Vericel Corp.、Zimmer Biomet Holdings Inc.などを分析しています。また、再生医療市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。
当調査会社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 再生医療の世界市場:用途別市場分析
7 再生医療の世界市場:技術別市場分析
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Technology
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global regenerative medicine market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global regenerative medicine market 2018 – 2022 ($ million)
o 4.2 Application Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Application Segment 2018 – 2022 ($ million)
o 4.3 Technology Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Technology Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Application – Market share 2023-2028 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Oncology – Market size and forecast 2023-2028
o Exhibit 34: Chart on Oncology – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Oncology – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Oncology – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Oncology – Year-over-year growth 2023-2028 (%)
o 6.4 Musculoskeletal – Market size and forecast 2023-2028
o Exhibit 38: Chart on Musculoskeletal – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Musculoskeletal – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Musculoskeletal – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Musculoskeletal – Year-over-year growth 2023-2028 (%)
o 6.5 Dermatology – Market size and forecast 2023-2028
o Exhibit 42: Chart on Dermatology – Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Dermatology – Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Dermatology – Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Dermatology – Year-over-year growth 2023-2028 (%)
o 6.6 Immunology and inflammation and others – Market size and forecast 2023-2028
o Exhibit 46: Chart on Immunology and inflammation and others – Market size and forecast 2023-2028 ($ million)
o Exhibit 47: Data Table on Immunology and inflammation and others – Market size and forecast 2023-2028 ($ million)
o Exhibit 48: Chart on Immunology and inflammation and others – Year-over-year growth 2023-2028 (%)
o Exhibit 49: Data Table on Immunology and inflammation and others – Year-over-year growth 2023-2028 (%)
o 6.7 Market opportunity by Application
o Exhibit 50: Market opportunity by Application ($ million)
o Exhibit 51: Data Table on Market opportunity by Application ($ million)
• 7 Market Segmentation by Technology
o 7.1 Market segments
o Exhibit 52: Chart on Technology – Market share 2023-2028 (%)
o Exhibit 53: Data Table on Technology – Market share 2023-2028 (%)
o 7.2 Comparison by Technology
o Exhibit 54: Chart on Comparison by Technology
o Exhibit 55: Data Table on Comparison by Technology
o 7.3 Cell and tissue-based – Market size and forecast 2023-2028
o Exhibit 56: Chart on Cell and tissue-based – Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Cell and tissue-based – Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Cell and tissue-based – Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Cell and tissue-based – Year-over-year growth 2023-2028 (%)
o 7.4 Gene therapy – Market size and forecast 2023-2028
o Exhibit 60: Chart on Gene therapy – Market size and forecast 2023-2028 ($ million)
o Exhibit 61: Data Table on Gene therapy – Market size and forecast 2023-2028 ($ million)
o Exhibit 62: Chart on Gene therapy – Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Gene therapy – Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Technology
o Exhibit 64: Market opportunity by Technology ($ million)
o Exhibit 65: Data Table on Market opportunity by Technology ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 71: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 75: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 79: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 83: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 87: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 Germany – Market size and forecast 2023-2028
o Exhibit 91: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.9 Japan – Market size and forecast 2023-2028
o Exhibit 95: Chart on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Japan – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Japan – Year-over-year growth 2023-2028 (%)
o 9.10 UK – Market size and forecast 2023-2028
o Exhibit 99: Chart on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.11 China – Market size and forecast 2023-2028
o Exhibit 103: Chart on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 104: Data Table on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 105: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 115: AbbVie Inc. – Overview
o Exhibit 116: AbbVie Inc. – Product / Service
o Exhibit 117: AbbVie Inc. – Key news
o Exhibit 118: AbbVie Inc. – Key offerings
o 12.4 Amgen Inc.
o Exhibit 119: Amgen Inc. – Overview
o Exhibit 120: Amgen Inc. – Product / Service
o Exhibit 121: Amgen Inc. – Key offerings
o 12.5 Baxter International Inc.
o Exhibit 122: Baxter International Inc. – Overview
o Exhibit 123: Baxter International Inc. – Business segments
o Exhibit 124: Baxter International Inc. – Key news
o Exhibit 125: Baxter International Inc. – Key offerings
o Exhibit 126: Baxter International Inc. – Segment focus
o 12.6 Becton Dickinson and Co.
o Exhibit 127: Becton Dickinson and Co. – Overview
o Exhibit 128: Becton Dickinson and Co. – Business segments
o Exhibit 129: Becton Dickinson and Co. – Key news
o Exhibit 130: Becton Dickinson and Co. – Key offerings
o Exhibit 131: Becton Dickinson and Co. – Segment focus
o 12.7 Cook Group Inc.
o Exhibit 132: Cook Group Inc. – Overview
o Exhibit 133: Cook Group Inc. – Product / Service
o Exhibit 134: Cook Group Inc. – Key offerings
o 12.8 Integra Lifesciences Corp.
o Exhibit 135: Integra Lifesciences Corp. – Overview
o Exhibit 136: Integra Lifesciences Corp. – Business segments
o Exhibit 137: Integra Lifesciences Corp. – Key news
o Exhibit 138: Integra Lifesciences Corp. – Key offerings
o Exhibit 139: Integra Lifesciences Corp. – Segment focus
o 12.9 Medtronic Plc
o Exhibit 140: Medtronic Plc – Overview
o Exhibit 141: Medtronic Plc – Business segments
o Exhibit 142: Medtronic Plc – Key news
o Exhibit 143: Medtronic Plc – Key offerings
o Exhibit 144: Medtronic Plc – Segment focus
o 12.10 Merck and Co. Inc.
o Exhibit 145: Merck and Co. Inc. – Overview
o Exhibit 146: Merck and Co. Inc. – Business segments
o Exhibit 147: Merck and Co. Inc. – Key news
o Exhibit 148: Merck and Co. Inc. – Key offerings
o Exhibit 149: Merck and Co. Inc. – Segment focus
o 12.11 MiMedx Group Inc.
o Exhibit 150: MiMedx Group Inc. – Overview
o Exhibit 151: MiMedx Group Inc. – Business segments
o Exhibit 152: MiMedx Group Inc. – Key news
o Exhibit 153: MiMedx Group Inc. – Key offerings
o Exhibit 154: MiMedx Group Inc. – Segment focus
o 12.12 Novartis AG
o Exhibit 155: Novartis AG – Overview
o Exhibit 156: Novartis AG – Business segments
o Exhibit 157: Novartis AG – Key offerings
o Exhibit 158: Novartis AG – Segment focus
o 12.13 Nuvasive Inc.
o Exhibit 159: Nuvasive Inc. – Overview
o Exhibit 160: Nuvasive Inc. – Business segments
o Exhibit 161: Nuvasive Inc. – Key news
o Exhibit 162: Nuvasive Inc. – Key offerings
o Exhibit 163: Nuvasive Inc. – Segment focus
o 12.14 Organogenesis Holdings Inc.
o Exhibit 164: Organogenesis Holdings Inc. – Overview
o Exhibit 165: Organogenesis Holdings Inc. – Product / Service
o Exhibit 166: Organogenesis Holdings Inc. – Key offerings
o 12.15 Smith and Nephew plc
o Exhibit 167: Smith and Nephew plc – Overview
o Exhibit 168: Smith and Nephew plc – Business segments
o Exhibit 169: Smith and Nephew plc – Key news
o Exhibit 170: Smith and Nephew plc – Key offerings
o Exhibit 171: Smith and Nephew plc – Segment focus
o 12.16 Thermo Fisher Scientific Inc.
o Exhibit 172: Thermo Fisher Scientific Inc. – Overview
o Exhibit 173: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 174: Thermo Fisher Scientific Inc. – Key news
o Exhibit 175: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 176: Thermo Fisher Scientific Inc. – Segment focus
o 12.17 Vericel Corp.
o Exhibit 177: Vericel Corp. – Overview
o Exhibit 178: Vericel Corp. – Product / Service
o Exhibit 179: Vericel Corp. – Key news
o Exhibit 180: Vericel Corp. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 181: Inclusions checklist
o Exhibit 182: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 183: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 184: Research methodology
o Exhibit 185: Validation techniques employed for market sizing
o Exhibit 186: Information sources
o 13.5 List of abbreviations
o Exhibit 187: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Market Segmentation by Technology
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global regenerative medicine market 2018 – 2022 ($ million)
Exhibits19: Historic Market Size – Application Segment 2018 – 2022 ($ million)
Exhibits20: Historic Market Size – Technology Segment 2018 – 2022 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Application – Market share 2023-2028 (%)
Exhibits31: Data Table on Application – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Oncology – Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Oncology – Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Oncology – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Oncology – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Musculoskeletal – Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Musculoskeletal – Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Musculoskeletal – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Musculoskeletal – Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Dermatology – Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Dermatology – Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Dermatology – Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Dermatology – Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Immunology and inflammation and others – Market size and forecast 2023-2028 ($ million)
Exhibits47: Data Table on Immunology and inflammation and others – Market size and forecast 2023-2028 ($ million)
Exhibits48: Chart on Immunology and inflammation and others – Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Immunology and inflammation and others – Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Application ($ million)
Exhibits51: Data Table on Market opportunity by Application ($ million)
Exhibits52: Chart on Technology – Market share 2023-2028 (%)
Exhibits53: Data Table on Technology – Market share 2023-2028 (%)
Exhibits54: Chart on Comparison by Technology
Exhibits55: Data Table on Comparison by Technology
Exhibits56: Chart on Cell and tissue-based – Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Cell and tissue-based – Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Cell and tissue-based – Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Cell and tissue-based – Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Gene therapy – Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Gene therapy – Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Gene therapy – Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Gene therapy – Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Technology ($ million)
Exhibits65: Data Table on Market opportunity by Technology ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Japan – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Japan – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK – Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on UK – Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on China – Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on China – Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. – Overview
Exhibits116: AbbVie Inc. – Product / Service
Exhibits117: AbbVie Inc. – Key news
Exhibits118: AbbVie Inc. – Key offerings
Exhibits119: Amgen Inc. – Overview
Exhibits120: Amgen Inc. – Product / Service
Exhibits121: Amgen Inc. – Key offerings
Exhibits122: Baxter International Inc. – Overview
Exhibits123: Baxter International Inc. – Business segments
Exhibits124: Baxter International Inc. – Key news
Exhibits125: Baxter International Inc. – Key offerings
Exhibits126: Baxter International Inc. – Segment focus
Exhibits127: Becton Dickinson and Co. – Overview
Exhibits128: Becton Dickinson and Co. – Business segments
Exhibits129: Becton Dickinson and Co. – Key news
Exhibits130: Becton Dickinson and Co. – Key offerings
Exhibits131: Becton Dickinson and Co. – Segment focus
Exhibits132: Cook Group Inc. – Overview
Exhibits133: Cook Group Inc. – Product / Service
Exhibits134: Cook Group Inc. – Key offerings
Exhibits135: Integra Lifesciences Corp. – Overview
Exhibits136: Integra Lifesciences Corp. – Business segments
Exhibits137: Integra Lifesciences Corp. – Key news
Exhibits138: Integra Lifesciences Corp. – Key offerings
Exhibits139: Integra Lifesciences Corp. – Segment focus
Exhibits140: Medtronic Plc – Overview
Exhibits141: Medtronic Plc – Business segments
Exhibits142: Medtronic Plc – Key news
Exhibits143: Medtronic Plc – Key offerings
Exhibits144: Medtronic Plc – Segment focus
Exhibits145: Merck and Co. Inc. – Overview
Exhibits146: Merck and Co. Inc. – Business segments
Exhibits147: Merck and Co. Inc. – Key news
Exhibits148: Merck and Co. Inc. – Key offerings
Exhibits149: Merck and Co. Inc. – Segment focus
Exhibits150: MiMedx Group Inc. – Overview
Exhibits151: MiMedx Group Inc. – Business segments
Exhibits152: MiMedx Group Inc. – Key news
Exhibits153: MiMedx Group Inc. – Key offerings
Exhibits154: MiMedx Group Inc. – Segment focus
Exhibits155: Novartis AG – Overview
Exhibits156: Novartis AG – Business segments
Exhibits157: Novartis AG – Key offerings
Exhibits158: Novartis AG – Segment focus
Exhibits159: Nuvasive Inc. – Overview
Exhibits160: Nuvasive Inc. – Business segments
Exhibits161: Nuvasive Inc. – Key news
Exhibits162: Nuvasive Inc. – Key offerings
Exhibits163: Nuvasive Inc. – Segment focus
Exhibits164: Organogenesis Holdings Inc. – Overview
Exhibits165: Organogenesis Holdings Inc. – Product / Service
Exhibits166: Organogenesis Holdings Inc. – Key offerings
Exhibits167: Smith and Nephew plc – Overview
Exhibits168: Smith and Nephew plc – Business segments
Exhibits169: Smith and Nephew plc – Key news
Exhibits170: Smith and Nephew plc – Key offerings
Exhibits171: Smith and Nephew plc – Segment focus
Exhibits172: Thermo Fisher Scientific Inc. – Overview
Exhibits173: Thermo Fisher Scientific Inc. – Business segments
Exhibits174: Thermo Fisher Scientific Inc. – Key news
Exhibits175: Thermo Fisher Scientific Inc. – Key offerings
Exhibits176: Thermo Fisher Scientific Inc. – Segment focus
Exhibits177: Vericel Corp. – Overview
Exhibits178: Vericel Corp. – Product / Service
Exhibits179: Vericel Corp. – Key news
Exhibits180: Vericel Corp. – Key offerings
Exhibits181: Inclusions checklist
Exhibits182: Exclusions checklist
Exhibits183: Currency conversion rates for US$
Exhibits184: Research methodology
Exhibits185: Validation techniques employed for market sizing
Exhibits186: Information sources
Exhibits187: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR41171-23 )"再生医療の世界市場2024~2028" (英文:Global Regenerative Medicine Market 2024-2028)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。